Nyxoah SA (NYXH)
8.00
-0.28
(-3.38%)
USD |
NASDAQ |
Nov 22, 16:00
7.99
-0.01
(-0.12%)
After-Hours: 20:00
Nyxoah EPS Diluted (Quarterly): -0.5455 for Sept. 30, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.5455 |
| June 30, 2024 | -0.4608 |
| March 31, 2024 | -0.4508 |
| December 31, 2023 | -0.4081 |
| September 30, 2023 | -0.2896 |
| June 30, 2023 | -0.4874 |
| March 31, 2023 | -0.4941 |
| December 31, 2022 | -0.5256 |
| September 30, 2022 | -0.2438 |
| Date | Value |
|---|---|
| June 30, 2022 | -0.2056 |
| March 31, 2022 | -0.2918 |
| December 31, 2021 | -0.2722 |
| September 30, 2021 | -0.4103 |
| June 30, 2021 | -0.3784 |
| March 31, 2021 | -0.3085 |
| June 30, 2020 | -0.1012 |
| March 31, 2020 | -0.1257 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.5455
Minimum
Sep 2024
-0.1012
Maximum
Jun 2020
-0.3529
Average
-0.3784
Median
Jun 2021
EPS Diluted (Quarterly) Benchmarks
| Galapagos NV | -0.8469 |
| UCB SA | -- |
| Mithra Pharmaceuticals SA | -- |
| Celyad Oncology SA | -- |
| MDxHealth SA | -0.40 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.76M |
| Revenue (Quarterly) | 1.392M |
| Total Expenses (Quarterly) | 17.87M |
| Enterprise Value | 241.66M |
| Gross Profit Margin (Quarterly) | 61.93% |
| Profit Margin (Quarterly) | -1.35K% |
| Earnings Yield | -23.32% |
| Normalized Earnings Yield | -22.45 |